Unknown

Dataset Information

0

Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models.


ABSTRACT: A significant challenge in the development of long-acting injectable drug formulations, especially for anti-infective agents, is delivering an efficacious dose within a tolerable injection volume. Co-administration of the extracellular matrix-degrading enzyme hyaluronidase can increase maximum tolerable injection volumes but is untested for this benefit with long-acting injectable formulations. One concern is that hyaluronidase could potentially alter the tissue response surrounding an injection depot, a response known to be important for drug release kinetics of long-acting injectable formulations. The objective of this pilot study was to evaluate the impact of co-administration of hyaluronidase on the drug release kinetics, pharmacokinetic profiles, and injection site histopathology of the long-acting injectable paliperidone palmitate for up to four weeks following intramuscular injection in mouse and rat models. In both species, co-administration of hyaluronidase increased paliperidone plasma exposures the first week after injection but did not negate the overall long-acting release nature of the formulation. Hyaluronidase-associated modification of the injection site depot was observed in mice but not in rats. These findings suggest that further investigation of hyaluronidase with long-acting injectable agents is warranted.

SUBMITTER: Pertinez H 

PROVIDER: S-EPMC10942359 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


A significant challenge in the development of long-acting injectable drug formulations, especially for anti-infective agents, is delivering an efficacious dose within a tolerable injection volume. Co-administration of the extracellular matrix-degrading enzyme hyaluronidase can increase maximum tolerable injection volumes but is untested for this benefit with long-acting injectable formulations. One concern is that hyaluronidase could potentially alter the tissue response surrounding an injection  ...[more]

Similar Datasets

| S-EPMC6088783 | biostudies-literature
| S-EPMC5048499 | biostudies-literature
| S-EPMC7384107 | biostudies-literature
| S-EPMC8203189 | biostudies-literature
| S-EPMC3593824 | biostudies-literature
| S-EPMC8929757 | biostudies-literature
| S-EPMC9095535 | biostudies-literature
| S-EPMC3431970 | biostudies-literature
| S-EPMC5683787 | biostudies-literature